IL6R and prostate carcinoma: IL-6Rα was detected at low levels in MDA-MB231 and PC3 cells (<2%; Figure 5B,F) relative to the unstained controls (Figure 5A,E), whereas its expression in C4-2B prostate-cancer cells reached ~93% (Figure 5D) relative to its unstained control (Figure 5C).